07 May 2019
EMA launches a social media campaign to highlight how the European medicines regulatory network keeps medicines available in Europe safe and effective. As of today, EMA will start sharing a series of info-cards on its Twitter and LinkedIn accounts.
The visuals describe the added value of European cooperation in keeping medicines safe, from the pooling of resources to better monitor and analyse safety information across the continent, to raising safety standards and allowing patients to directly report side effects and identify legally operating online pharmacies and retailers.
‘Keeping medicines safe’ is a priority for EMA, the European Commission and the network of national competent authorities which provides the Agency with the best-available scientific expertise in the EU for the regulation of medicines.
EMA encourages stakeholders to support the campaign by sharing the info-cards on social media.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024